Ophthalmological abnormalities in children with congenital disorders of glycosylation type I

被引:41
作者
Morava, E. [1 ]
Wosik, H. N. [1 ,2 ,3 ]
Sykut-Cegielska, J.
Adamowicz, M. [4 ]
Guillard, M. [5 ]
Wevers, R. A. [5 ]
Lefeber, D. J. [5 ]
Cruysberg, J. R. M. [6 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6500 HB Nijmegen, Netherlands
[2] Med Univ Lodz, Lodz, Poland
[3] Childrens Mem Hlth Inst, Dept Metab Dis Endocrinol & Diabetol, Warsaw, Poland
[4] Childrens Mem Hlth Inst, Dept Metab Dis Endocrinol & Diabetol, Warsaw, Poland
[5] Radboud Univ Nijmegen, Med Ctr, Lab Pediat & Neurol, NL-6525 ED Nijmegen, Netherlands
[6] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands
关键词
DEFICIENT GLYCOPROTEIN SYNDROME; CDG; MUTATIONS; GENE; MANIFESTATION; PHENOTYPE; SUBTYPE; PATIENT; ORIGIN; DEFECT;
D O I
10.1136/bjo.2008.145359
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: Children with congenital disorders of glycosylation (CDG) type la frequently present with ocular involvement and visual loss. Little is known, however, about the occurrence of ophthalmological abnormalities in other subtypes of CDG syndrome. Methods: We evaluated 45 children sequentially diagnosed with CDG type I for the presence of ocular abnormalities at the time of the diagnosis and during follow-up. We compared the various ophthalmic findings in the different CDG subgroups. Results: Of the 45 patients, 22 had CDG type la, nine had CDG type lc and 14 had a so-far undiagnosed biochemical background (CDG type lx). We found ocular anomalies in 28 of the 45 children. Three had unique findings, including congenital cataract, retinal coloboma and glaucoma. A few CDG type la patients showed a sequential occurrence of symptoms, including retinitis pigmentosa or cataract. Conclusions: Ophthalmic findings are frequent in CDG syndrome involving both the anterior and posterior segment of the eye. The disorder might lead to abnormal development of the lens or the retina, cause diminished vision, alter ocular motility and intraocular pressure. We suggest routine screening and follow-up for ophthalmological anomalies in all children diagnosed with CDG syndrome to provide early treatment and adequate counselling.
引用
收藏
页码:350 / 354
页数:5
相关论文
共 24 条
[1]   Carbohydrate-deficient glycoprotein syndrome type 1 with profound thrombocytopenia and normal phosphomannomutase and phosphomannose isomerase activities [J].
Acarregui, MJ ;
George, TN ;
Rhead, WJ .
JOURNAL OF PEDIATRICS, 1998, 133 (05) :697-700
[2]  
Assmann B, 2001, NEUROPEDIATRICS, V32, P313
[3]   Intracranial hemorrhage as the initial manifestation of a congenital disorder of glycosylation [J].
Cohn, Ronald D. ;
Eklund, Erik ;
Bergner, Amanda L. ;
Casella, James F. ;
Woods, S. Lee ;
Althaus, Janyne ;
Blakemore, Karin J. ;
Fox, Harold E. ;
Hoover-Fong, Julie E. ;
Hamosh, Ada ;
Braverman, Nancy E. ;
Freeze, Hudson H. ;
Boyadjiev, Simeon A. .
PEDIATRICS, 2006, 118 (02) :E514-E521
[4]   A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases [J].
de Lonlay, P ;
Seta, N ;
Barrot, S ;
Chabrol, B ;
Drouin, V ;
Gabriel, BM ;
Journel, H ;
Kretz, M ;
Laurent, J ;
Le Merrer, M ;
Leroy, A ;
Pedespan, D ;
Sarda, P ;
Villeneuve, N ;
Schmitz, J ;
van Schaftingen, E ;
Matthijs, G ;
Jaeken, J ;
Korner, C ;
Munnich, A ;
Saudubray, JM ;
Cormier-Daire, V .
JOURNAL OF MEDICAL GENETICS, 2001, 38 (01) :14-19
[5]   Congenital disorder of glycosylation type Id: Clinical phenotype, molecular analysis, prenatal diagnosis, and glycosylation of fetal proteins [J].
Denecke, J ;
Kranz, C ;
Von Kleist-Retzow, JC ;
Bosse, K ;
Herkenrath, P ;
Debus, O ;
Harms, E ;
Marquardt, T .
PEDIATRIC RESEARCH, 2005, 58 (02) :248-253
[6]   An activated 5′ cryptic splice site in the human ALG3 gene generates a premature termination codon insensitive to nonsense-mediated mRNA decay in a new case of congenital disorder of glycosylation type Id (CDG-Id) [J].
Denecke, J ;
Kranz, C ;
Kemming, D ;
Koch, HG ;
Marquardt, T .
HUMAN MUTATION, 2004, 23 (05) :477-486
[7]   Congenital disorder of glycosylation (CDG)-Ih patient with a severe hepato-intestinal phenotype and evolving central nervous system pathology [J].
Eklund, EA ;
Sun, LW ;
Westphal, V ;
Northrop, JL ;
Freeze, HH ;
Scaglia, F .
JOURNAL OF PEDIATRICS, 2005, 147 (06) :847-850
[8]   Scandinavian CDG-Ia patients:: genotype/phenotype correlation and geographic origin of founder mutations [J].
Erlandson, A ;
Bjursell, C ;
Stibler, H ;
Kristiansson, B ;
Wahlström, J ;
Martinsson, T .
HUMAN GENETICS, 2001, 108 (05) :359-367
[9]   Congenital disorder of glycosylation (CDG) type Ie.: A new patient [J].
García-Silva, MT ;
Matthijs, G ;
Schollen, E ;
Cabrera, JC ;
Del Pozo, JS ;
Herreros, MM ;
Simón, R ;
Maties, M ;
Hernández, EM ;
Hennet, T ;
Briones, P .
JOURNAL OF INHERITED METABOLIC DISEASE, 2004, 27 (05) :591-600
[10]   ALG12 mannosyltransferase defect in congenital disorder of glycosylation type Ig [J].
Grubenmann, CE ;
Frank, CG ;
Kjaergaard, S ;
Berger, EG ;
Aebi, M ;
Hennet, T .
HUMAN MOLECULAR GENETICS, 2002, 11 (19) :2331-2339